Clinical Trial Update: Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on mosunetuzumab in combination with platinum-based salvage chemotherapy for relapsed/refractory aggressive B-cell lymphomas; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma Grade 3b
• High-grade B-cell Lymphoma
• Transformed B-cell Lymphoma

Drugs mentioned

• LUNSUMIO (mosunetuzumab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Large B-cell Lymphoma, High-grade B-cell Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING